Styrax Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 16.40 Cr
- Paid Up Capital ₹ 6.57 Cr
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 224.22 Cr
- Satisfied Charges ₹ 36.92 Cr
- Revenue Growth 39.31%
- Profit Growth 56.78%
- Ebitda 60.76%
- Net Worth 28.98%
- Total Assets 42.25%
About Styrax Life Sciences
Styrax Life Sciences Private Limited (SLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 March 2014 and has a history of Ten years and ten months. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Corporate was formerly known as Beatus Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 16.40 Cr and a paid-up capital of Rs 6.57 Cr.
The company currently has active open charges totaling ₹224.22 Cr. The company has closed loans amounting to ₹36.92 Cr, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232AP2014PTC093548
-
Company No.
093548
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Mar 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Styrax Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmi Suryadevara
|
Director | 14-Mar-2014 | Current |
|
Suryadevara Rao
|
Director | 14-Mar-2014 | Current |
Financial Performance of Styrax Life Sciences.
Styrax Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.31% increase. The company also saw a substantial improvement in profitability, with a 56.78% increase in profit. The company's net worth Soared by an impressive increase of 28.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Styrax Life Sciences?
In 2023, Styrax Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Styrax Pharma Private LimitedLakshmi Suryadevara and Suryadevara Rao are mutual person
-
Styrax Laboratories Private LimitedLakshmi Suryadevara and Suryadevara Rao are mutual person
-
Auctus Life Sciences Llp
Suryadevara Rao is a mutual person
Charges (Loans)
₹224.22 Cr
₹36.92 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 108.40 Cr
- Others : 99.17 Cr
- Axis Bank Limited : 15.00 Cr
- Sidbi : 1.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2024 | Others | ₹10.00 Cr | Open |
| 29 Mar 2024 | Sidbi | ₹1.65 Cr | Open |
| 04 Oct 2023 | Others | ₹16.00 Cr | Open |
| 07 Aug 2023 | Others | ₹20.00 Cr | Open |
| 30 Jun 2023 | Others | ₹6.87 Cr | Open |
How Many Employees Work at Styrax Life Sciences?
Styrax Life Sciences has a workforce of 202 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Styrax Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styrax Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.